TPET · Trio Petroleum Corp

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Randall in 2025.

Based upon shares sold at an average of $0.2793. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Pernice in 2025.

Based upon shares sold at an average of $0.3619. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Ross in 2025.

Based upon shares sold at an average of $0.3888. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Pernice in 2025.

Based upon shares sold at an average of $0.4615. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Ross in 2025.

Based upon shares sold at an average of $0.4658. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Randall in 2025.

Based upon shares sold at an average of $0.51. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Pernice in 2025.

Based upon shares sold at an average of $0.4952. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Ross in 2025.

Based upon shares sold at an average of $0.5424. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Pernice in 2025.

Based upon shares sold at an average of $1.7518. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Ross in 2025.

Based upon shares sold at an average of $1.5109. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Pernice in 2025.

Based upon shares sold at an average of $0.43640. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Ross in 2025.

Based upon shares sold at an average of $0.4749. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Randall in 2025.

Based upon shares sold at an average of $$0.6391. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

1 The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Ross in 2025.

Based upon shares sold at an average of $0.8894. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Pernice in 2025.

Based upon shares sold at an average of $0.82630. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is to cover taxes with respect to the issuance of restricted stock to Mr. Pernice in 2025.

Based upon shares sold at an average of $1.0363. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

Represents 175,000 restricted stock of the issuer awarded to Mr. Hunter under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.

Mr. Eschner resigned from his position as Vice Chairman and Director of the Issuer on August 1, 2025.

Represents 15,000 restricted stock of the issuer provided to Mr. Eschner under the 2022 Equity Incentive Plan (the "2022 Plan"), as compensation pursuant to the Consulting Agreement dated August 1, 2025, between Mr. Eschner and the Issuer, and which restricted stock vested upon issuance.

Consists of (i) 25,000 shares held by the Stanford Eschner Trust No. 1, for which Mr. Eschner holds investment and voting control over; the address of the Stanford Eschner Trust No. 1 is 6501 Kane Way, Bakersfield, CA 93309, (ii) 25,000 shares held by Trio LLC, a California Limited Liability Company, for which Mr. Eschner serves as the Executive Chairman, and as such may be deemed to hold investment and voting control over Trio LLC's shares; the address of Trio LLC is 4115 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506, and (iii) 7,500 shares held by Stanford Eschner himself, excluding the 15,000 restricted stock issued to Mr. Eschner on August 1, 2025.

Represents 175,000 restricted stock of the issuer awarded to Mr. Randall under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.

Represents 62,500 restricted stock of the issuer awarded to Mr. Overholtzer under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.

Represents 250,000 restricted stock of the issuer awarded to Mr. Pernice under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.

Represents 625,000 restricted stock of the issuer awarded to Mr. Ross under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.

Represents 250,000 restricted stock of the issuer awarded to Mr. Blake under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.

Based upon shares sold at an average of $$1.2455. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.

The price reported in Column 4 is a weighted average price of $1.73. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.

The price reported in Column 4 is a weighted average price of $1.0841. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

All share amounts reflect a reverse stock split of the common stock of the issuer effective November 14, 2024, at a ratio of 1 share of common stock for each 20 shares of common stock then outstanding.

Represents 12,500 shares of restricted stock of the issuer awarded to Mr. William Hunter under the 2022 Equity Incentive Plan (the "2022 Plan"). The board of directors (the "Board") approved an award under the 2022 Plan of 12,500 shares of restricted stock as compensation. The 12,500 shares of restricted stock were issued to Mr. Hunter on December 4, 2024. All of the 12,500 shares of restricted stock will vest on January 21, 2025, subject to Mr. Hunter's continued service to the issuer on the vesting date.

All share amounts reflect a reverse stock split of the common stock of the issuer effective November 14, 2024, at a ratio of 1 share of common stock for each 20 shares of common stock then outstanding.

Represents 12,500 shares of restricted stock of the issuer awarded to Mr. James Blake under the 2022 Equity Incentive Plan (the "2022 Plan"). The board of directors (the "Board") approved an award under the 2022 Plan of 12,500 shares of restricted stock as compensation. The 12,500 shares of restricted stock were issued to Mr. Blake on December 4, 2024. All of the 12,500 shares of restricted stock will vest on April 21, 2025, subject to Mr. Blake's continued service to the issuer on the vesting date.

All share amounts reflect a reverse stock split of the common stock of the issuer effective November 14, 2024, at a ratio of 1 share of common stock for each 20 shares of common stock then outstanding.

Represents 12,500 shares of restricted stock of the issuer awarded to Mr. Thomas Pernice under the 2022 Equity Incentive Plan (the "2022 Plan"). The board of directors (the "Board") approved an award under the 2022 Plan of 12,500 shares of restricted stock as compensation. The 12,500 shares of restricted stock were issued to Mr. Pernice on December 4, 2024. All of the 12,500 shares of restricted stock will vest on January 21, 2025, subject to Mr. Pernice's continued service to the issuer on the vesting date.

All share amounts reflect a reverse stock split of the common stock of the issuer effective November 14, 2024, at a ratio of 1 share of common stock for each 20 shares of common stock then outstanding.

Represents 12,500 shares of restricted stock of the issuer awarded to Mr. John Randall under the 2022 Equity Incentive Plan (the "2022 Plan"). The board of directors (the "Board") approved an award under the 2022 Plan of 12,500 shares of restricted stock as compensation. The 12,500 shares of restricted stock were issued to Mr. Randall on December 4, 2024. All of the 12,500 shares of restricted stock will vest on January 21, 2025, subject to Mr. Randall's continued service to the issuer on the vesting date.

All share amounts reflect a reverse stock split of the common stock of the issuer effective November 14, 2024, at a ratio of 1 share of common stock for each 20 shares of common stock then outstanding.

Represents 10,000 shares of restricted stock of the issuer awarded to Mr. Greg Overholtzer under the 2022 Equity Incentive Plan (the "2022 Plan"). The board of directors (the "Board") approved an award under the 2022 Plan of 10,000 shares of restricted stock as compensation. The 10,000 shares of restricted stock were issued to Mr. Overholtzer on December 4, 2024. All of the 10,000 shares of restricted stock will vest on April 21, 2025, subject to Mr. Overholtzer's continued service to the issuer on the vesting date.

All share amounts reflect a reverse stock split of the common stock of the issuer effective November 14, 2024, at a ratio of 1 share of common stock for each 20 shares of common stock then outstanding.

Represents 100,000 shares of restricted stock of the issuer awarded to Mr. Ross under the 2022 Plan. The 100,000 shares of restricted stock will vest as follow: 25,000 shares of restricted stock (25%) will vest on January 9, 2025 (which is six months after the date of award), and the remaining 75,000 shares of restricted stock will vest quarterly thereafter for an additional 25,000 RSUs on each of April 9, 2025, July 9, 2025 and October 9, 2025, subject to Mr. Ross's continued service to the issuer on each applicable vesting date.

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.

The price reported in Column 4 is a weighted average price of $0.1535. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

All share amounts reflect a reverse stock split of the common stock of the issuer effective November 14, 2024, at a ratio of 1 share of common stock for each 20 shares of common stock then outstanding.

Represents 27,500 restricted stock units ("RSUs") of the issuer with each RSU representing a contingent right to receive one share of common stock of the issuer under its 2022 Equity Incentive Plan (the "2022 Plan"). Mr. Ross received the 27,500 RSUs on August 15, 2024. The RSUs will vest as follows: 6,875 RSUs (25%) will vest on December 19, 2024, and the remaining 20,625 RSUs (75%) will vest quarterly thereafter for an additional 6,875 RSUs on each of March 19, 2025, June 19, 2025, and September 19, 2025, subject to Mr. Ross's continued service to the issuer on each applicable vesting date.

These shares of common stock were sold pursuant to a 10b5-1 plan, that the reporting person and Brightening Lives Foundation Inc. ("BLF") entered into on March 20, 2024 . Mr. Ingriselli is the Chief Executive Officer of BLF and holds investment and voting control over such shares. The address of BLF is 9000 Crow Canyon Road, Suite 362, Danville, CA 94506. Prior to these sales, BLF held 257,000 shares of common stock of the issuer. Mr. Ingriselli may be deemed to have beneficial ownership of the shares of common stock held by BLF. Mr. Ingriselli disclaims beneficial ownership of the shares of common stock held by BLF reported herein, except to the extent of his pecuniary interest therein.

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.

The price reported in Column 4 is a weighted average price of $0.311. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

These shares of common stock were sold pursuant to a 10b5-1 plan that the reporting person and Global Venture Investments LLC ("GVI") entered into on March 20, 2024. Mr. Ingriselli holds 100% of the membership interests of GVI and, as a result, is deemed to hold investment and voting control over those shares. On June 27, 2024 GVI sold 280,000 shares of common stock. Prior to these sales GVI held 280,000 shares of common stock of the issuer. The address of GVI is 4115 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506. Mr. Ingriselli may be deemed to have beneficial ownership of the shares of common stock held by GVI. Mr. Ingriselli disclaims beneficial ownership of the shares of common stock held by GVI reported herein, except to the extent of his pecuniary interest therein.

Represents 450,000 restricted stock units ("RSUs") of the issuer with each RSU representing a contingent right to receive one share of Common Stock of the issuer under its 2022 Equity Incentive Plan, subject to Mr. Ross's continued service to the issuer on each applicable vesting date. On June 17, 2024, Mr. Ross was appointed to the board of directors of the issuer and received 450,000 RSUs on June 19, 2024 in connection with such appointment. The 450,000 RSUs will vest as follows, 112,500 RSUs (25%) will vest on December 19, 2024 (which is six months after the date the RSUs were awarded), and the remaining 337,500 RSUs (75%) will vest quarterly thereafter for an additional 84,375 RSUs on each of March 19, 2024, June 19, 2024, September 19, 2024 and December 19, 2024.

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.

The price reported in Column 4 is a weighted average price of $0.2270. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.3301 to $0.3302, inclusive. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

These shares of common stock were sold pursuant to a 10b5-1 plan that the reporting person entered into on October 26, 2023. On February 9, 2024 Mr. Randall sold 60,000 shares of common stock. Prior to these sales Mr. Randall held 160,000 shares of common stock of the issuer.

These shares of common stock were sold pursuant to a 10b5-1 plan that the reporting person and Global Venture Investments LLC ("GVI") entered into on October 25, 2023. Mr. Ingriselli holds 100% of the membership interests of GVI and, as a result, is deemed to hold investment and voting control over those shares. On January 31, 2024 GVI sold 362,704 shares of common stock and then sold an additional 137,296 shares of common stock on February 1, 2024. Prior to these sales GVI held 600,000 shares of common stock of the issuer. The address of GVI is 4115 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506. Mr. Ingriselli may be deemed to have beneficial ownership of the shares of common stock held by GVI. Mr. Ingriselli disclaims beneficial ownership of the shares of common stock held by GVI reported herein, except to the extent of his pecuniary interest therein.

These shares of common stock were sold pursuant to a 10b5-1 plan that the reporting person and his wife, Sung Jin Ingriselli, entered into on October 25, 2023. Ms. Ingriselli sold 150,000 shares of common stock of the issuer. After this sale, Ms. Ingriselli no longer holds any shares of common stock of the issuer. The address of Ms. Ingriselli is 34 Magnolia Place, Danville, CA 94506. Mr. Ingriselli may be deemed to have had beneficial ownership of these shares of common stock.

These shares of common stock were sold pursuant to a 10b5-1 plan that the reporting person and Global Venture Investments LLC ("GVI") entered into on October 25, 2023. Mr. Ingriselli holds 100% of the membership interests of GVI and, as a result, is deemed to hold investment and voting control over those shares. On January 31, 2024 GVI sold 362,704 shares of common stock and then sold an additional 137,296 shares of common stock on February 1, 2024. Prior to these sales GVI held 600,000 shares of common stock of the issuer. The address of GVI is 4115 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506. Mr. Ingriselli may be deemed to have beneficial ownership of the shares of common stock held by GVI. Mr. Ingriselli disclaims beneficial ownership of the shares of common stock held by GVI reported herein, except to the extent of his pecuniary interest therein.

Mr. Ingriselli made a contribution of 210,000 shares of common stock to Brightening Lives Foundation Inc., which prior to such contribution owned 197,000 shares of common stock of the issuer. Mr. Ingriselli is the Chief Executive Officer and holds investment and voting control; the address of the Brightening Lives Foundation Inc is 9000 Crow Canyon Road, Suite 362, Danville, CA 94506. Mr. Ingriselli may be deemed to have beneficial ownership of the shares held by the aforementioned entity. Mr. Ingriselli disclaims beneficial ownership of the shares held by Brightening Lives Foundation Inc reported herein, except to the extent of his pecuniary interest therein.

Mr. Peterson was awarded 1,000,000 shares of restricted stock (the "Stock Grant"), pursuant to the Issuer's 2022 Equity Incentive Plan (the "2022 Plan"), under the terms of an employment agreement entered into between the Issuer and Mr. Peterson, who became the Issuer's Chief Executive Officer, effective as of October 23, 2023. The Stock Grant has a vesting schedule in which the first 250,000 shares of restricted stock will vest on April 23, 2024, and the remainder shall vest in equal tranches of 250,000 shares each on October 23, 2024, April 23, 2025 and October 23, 2025, subject to Mr. Peterson's remaining in Continuous Service (as such term is defined under the 2022 Plan) with the Company as of each of those dates.

The shares of restricted stock were awarded as a bonus under Mr. Peterson's employment agreement in connection with his services as the Chief Executive Officer of the Issuer.

Mr. Hunter was awarded 100,000 shares of restricted stock, pursuant to the Issuer's 2022 Equity Incentive Plan. All of the shares of restricted stock vest on February 29, 2024, subject to Mr. Hunter continuing to be a director to the Company on such date.

The shares of restricted stock were awarded as a bonus in connection with Mr. Hunter's services as an independent director of the Issuer.